TABLE 1.
Worldwide and regional distribution of participants by age, sex and use of antihypertensive medication
| Female | Male | ||||
| Region | Total participants | Total | Mean age (years) | Total | Mean age (years) |
| East Asia | 222 614 (34.7%) | 114 832 (51.6%) | 46.5 | 107 722 (48.4%) | 47.6 |
| Americas | 156 513 (24.4%) | 93 310 (59.9%) | 49.6 | 62 528 (40.1%) | 51.6 |
| South-east Asia and Australasia | 89 631 (14.0%) | 44 339 (49.9%) | 44.6 | 44 288 (49.9%) | 41.8 |
| Sub-Saharan Africa | 73 880 (11.5%) | 35 422 (48.0%) | 41.4 | 38 300 (51.9%) | 39.8 |
| South Asia | 59 946 (9.3%) | 22 637 (37.9%) | 40.8 | 37 152 (62.1%) | 43.7 |
| Europe | 38 327 (6.0%) | 22 719 (59.3%) | 50.1 | 15 550 (40.6%) | 52.0 |
| Northern Africa and Middle East | 1146 (0.2%) | 706 (61.6%) | 46.5 | 440 (38.4%) | 48.0 |
| Worldwide | 642 057 | 333 965 (52.2%) | 46.4 | 305 980 (47.8%) | 46.4 |